C12N2710/16111 - CPC Classification Index

ClassID:

109780 ⎘

C12N2710/16111 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae Cytomegalovirus, e.g. human herpesvirus 5

Sub-classes:

C12N2710/16121 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 25
C12N2710/16122 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 172
C12N2710/16123 » Virus like particles [VLP] 3
C12N2710/16131 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 1
C12N2710/16132 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 9
C12N2710/16133 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 12
C12N2710/16134 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 244
C12N2710/16141 » Use of virus, viral particle or viral elements as a vector 7
C12N2710/16151 » Methods of production or purification of viral material 33
C12N2710/16161 » Methods of inactivation or attenuation 7
C12N2710/16171 » Demonstrated in vivo effect 44
C12N2710/16188 » For redistribution 0

Recent Application in this class:

20260116934

2026-04-30

Compositions and Methods for Delivering CFTR Polypeptides

20250228933

2025-07-17

Human Cytomegalovirus Immunogenic Composition

20250011732

2025-01-09

SCALABLE CHROMATOGRAPHY PROCESS FOR PURIFICATION OF HUMAN CYTOMEGALOVIRUS

20210317174

2021-10-14

COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES

20210087245

2021-03-25

COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES

20210047626

2021-02-18

Scalable chromatography process for purification of human cytomegalovirus

20200254060

2020-08-13

Compositions and methods for delivering CFTR polypeptides

20190117766

2019-04-25

Vaccine against beta-herpesvirus infection and use thereof

20190099479

2019-04-04

Recombinant HCMV and RHCMV vectors and uses thereof

#10

20180305665

2018-10-25

Method for enrichment and expansion of virus antigen-specific T cells

#11

20160130308

2016-05-12

Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

#12

20160114027

2016-04-28

Recombinant HCMV and RHCMV vectors and uses thereof

#13

20150164634

2015-06-18

Reducing immunogenicity of xenogeneic transplant tissues

#14

20140079725

2014-03-20

Immune suppressor and its use

#15

20140023673

2014-01-23

Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

#16

20130202638

2013-08-08

Vaccine against beta-herpesvirus infection and use thereof

#17

20130136768

2013-05-30

Recombinant HCMV and RHCMV vectors and uses thereof

#18

20080160524

2008-07-03

Methods and Compositions for Detecting Target Sequences

#19

20070098741

2007-05-03

Vectors derived from antibodies for transferring substances into cells

#20

20060179499

2006-08-10

Non-human animal models for diabetic complications and their uses

#21

20060147939

2006-07-06

Compositions and methods for detecting human herpesviruses